within Pharmacolibrary.Drugs.ATC.R;

model R02AB01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.02,
    Cl             = 90 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,
    adminCount     = 1,
    Vd             = 0.0003,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0003333333333333333,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Neomycin is an aminoglycoside antibiotic used primarily for its local effects in the gastrointestinal tract to treat hepatic encephalopathy and to reduce gut flora prior to bowel surgery. It is not significantly absorbed from the gastrointestinal tract when administered orally and is rarely used systemically due to its nephrotoxicity and ototoxicity. While neomycin is approved for use in some topical and oral formulations, its systemic use is limited.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics estimated for adult individuals based on available literature; neomycin is poorly absorbed after oral administration, and reported systemic PK data are extremely limited.</p><h4>References</h4><ol><li><p>Liu, Y, et al., &amp; Zhang, S (2021). Pharmacokinetics of neomycin sulfate after intravenous and oral administrations in swine. <i>Journal of veterinary pharmacology and therapeutics</i> 44(5) 850–853. DOI:<a href=&quot;https://doi.org/10.1111/jvp.12981&quot;>10.1111/jvp.12981</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34165196/&quot;>https://pubmed.ncbi.nlm.nih.gov/34165196</a></p></li><li><p>Aschbacher, PW, &amp; Feil, VJ (1994). Neomycin metabolism in calves. <i>Journal of animal science</i> 72(3) 683–689. DOI:<a href=&quot;https://doi.org/10.2527/1994.723683x&quot;>10.2527/1994.723683x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8181985/&quot;>https://pubmed.ncbi.nlm.nih.gov/8181985</a></p></li><li><p>Kavanagh, KT, &amp; McCabe, BF (1983). Ototoxicity of oral neomycin and vancomycin. <i>The Laryngoscope</i> 93(5) 649–653. DOI:<a href=&quot;https://doi.org/10.1002/lary.1983.93.5.649&quot;>10.1002/lary.1983.93.5.649</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6843260/&quot;>https://pubmed.ncbi.nlm.nih.gov/6843260</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end R02AB01;
